Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
Frequently asked questions
What sector does Spineway (ALSPW) operate in?
Spineway belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Spineway (ALSPW) current stock price?
As of the latest data, Spineway stock price is €0.13, with a previous close of €0.13.
What is Spineway (ALSPW) current market capitalization?
Spineway market cap is approximately 4.62 million.
What is Spineway (ALSPW) Earnings Per Share (EPS)?
The trailing EPS is -€0.06, and the forward EPS is -€0.06.
What is Spineway (ALSPW) EBITDA?
Spineway EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.24 million.
Does Spineway (ALSPW) pay dividends?
No. Spineway does not pay a dividend.
What is Spineway (ALSPW) beta (volatility) score?
Spineway has a beta of 0.262, indicating lower volatility than the overall market.